FDA 483 - Society Hill Reproductive Medicine - April 11, 2024

Society Hill Reproductive Medicine in Philadelphia was inspected regarding its reproductive HCT/P operations. The inspection revealed that HCT/P donors were not properly determined eligible due to the use of an outdated Zika Virus risk assessment list, which omitted relevant countries. This indicates a failure in donor screening procedures and non-compliance with the firm's standard operating procedure.